Exon junction complex shapes the m<sup>6</sup>A epitranscriptome.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36550132.
- Also identified by DOI 10.1038/s41467-022-35643-1 and PMC identifier 9780246.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
N6-methyladenosine (m<sup>6</sup>A), the most abundant modification of mRNA, is essential for normal development and dysregulation promotes cancer. m<sup>6</sup>A is highly enriched in the 3' untranslated region (UTR) of a large subset of mRNAs to influence mRNA stability and/or translation. However, the mechanism responsible for the observed m<sup>6</sup>A distribution remains enigmatic. Here we find the exon junction complex shapes the m<sup>6</sup>A landscape by blocking METTL3-mediated m<sup>6</sup>A modification close to exon junctions within coding sequence (CDS). Depletion of EIF4A3, a core component of the EJC, causes increased METTL3 binding and m<sup>6</sup>A modification of short internal exons, and sites close to exon-exon junctions within mRNA. Reporter gene experiments further support the role of splicing and EIF4A3 deposition in controlling m<sup>6</sup>A modification via the local steric blockade of METTL3. Our results explain how characteristic patterns of m<sup>6</sup>A mRNA modification are established and uncover a role of the EJC in shaping the m<sup>6</sup>A epitranscriptome.
Medical subject headings
- RNA Splicing
- Cell Nucleus